- 专利标题： HDAC INHIBITORS, ALONE OR IN COMBINATION WITH BTK INHIBITORS, FOR TREATING NON-HODGKIN'S LYMPHOMA
-
申请号： EP14853051申请日： 2014-10-07
-
公开(公告)号： EP3054954A4公开(公告)日： 2017-12-13
- 发明人: QUAYLE STEVEN NORMAN , JONES SIMON S , SOTOMAYOR EDUARDO M , PINILLA-IBARZ JAVIER , SAHAKIAN EVA
- 申请人： ACETYLON PHARMACEUTICALS INC , MOFFITT CANCER CENTER
- 专利权人： ACETYLON PHARMACEUTICALS INC,MOFFITT CANCER CENTER
- 当前专利权人： ACETYLON PHARMACEUTICALS INC,MOFFITT CANCER CENTER
- 优先权： US201361889200 2013-10-10; US201361911091 2013-12-03
- 主分类号： A61K31/505
- IPC分类号： A61K31/505 ; A61K31/519 ; A61P35/00 ; C07D239/42
摘要：
The invention relates to HDAC inhibitors, or combinations comprising an HDAC inhibitor and a BTK inhibitor for the treatment of non-hodgkin's lymphoma in a subject in need thereof. Also provided herein are methods for treating non-hodgkin's lymphoma in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor, or a combination comprising an HDAC inhibitor and a BTK inhibitor.
信息查询
